In vitro susceptibilities of common pediatric pathogens to LY163892

Open Access

1 February 1988

journal article
research article
Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy

Vol. 32 (2) , 268-270
https://doi.org/10.1128/aac.32.2.268

Abstract

LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against beta-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.